the role of n-acetylcysteine treatment on anti-oxidative status in patients with type ii diabetes mellitus

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 17, Issue 4, 2006, Pages 245-254

  Ozkilic, Anil Cagla ^a   Cengiz, Mujgan ^a   Ozaydin, A ^a   Kanigur, Gonul ^a   Cobanoglu, Aysegul ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ASCORBIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN GLYCOSYLATION;

ACETYLCYSTEINE; ADULT; AGED; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, TYPE 2; ENZYMES; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED;

EID: 33847141501     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2006.17.4.245     Document Type: Article

References (37)

1. Cerello, A. Oxidative stress and giycemic regulation. Metabolism 2000; 49 (Suppl 1): 27–29.
2. Kaji, H, Jurasaki, M, Ito, K. Increased lipid peroxide value and glutathione peroxidase activity in blood plasma of Type 2 (non-insulin-dependent) diabetic woman. Klin Wochenschr 1985; 63: 765–768.
3. Baynes, JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405–412.
4. Beutler, E, Duron, 0, Kelly, MB. Improved method for determination of blood glutathione. J Lab Clin Med 1963; 61: 882–888.
5. Mekinova, D, Chorvatova, V, Volkovova, K, Staruchova, M, Grancicova, E, Klvanova, J, Ondreicka, R. Effectc of intake of exogenous vitamins, C, E and β-carotene on the antioxidative status in kidneys of rats with streptozoticin-induced diabetes. Nahrung 1995; 39: 257–261.
6. Wohaieb, SA, Godin, DV. Alterations in free radical tissue-defense mechanism in streptozotocin-induced diabetes in rat. Diabetes 1987; 36: 1014–1018.
7. Ziment, I. Acetylcysteine: a drug that is much more than a mucocynetic. Biomed Pharmocother 1988; 42: 513–520.
8. De Flora, S, Bennicelli, C, Camoirano, A, Serra, D, Romano, M, Rossi, GA, Morelli, A, De Flora, A. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and or mutagenic compounds. Carcinogenesis 1985; 6: 1735–1745.
9. Nakata, K, Kawase, M, Ogino, S, Kinoshita, C, Murata, H, Sakave, T, Ogata, K, Ohmari, S. Effects on age of levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione levels of mouse with cysteine derivatives. Mech. Ageing. Dev 1996; 90: 195–207.
10. Straface, E, Rivabene, R, Masella, R, Santulli, M, Paganelli, R, Malorni, W. Structural changes of the erythrcyte as a marker of non-insulin dependent diabetes: protective effect of N-acetylcysteine. Biochem Biophys Res Commun 2002; 290(5): 1393–1398.
11. Beutler, E, Duron, 0, Kelly, MB. Improved method for determination of blood glutathione. J Lab Clin Med 1963; 61: 882–888.
12. Habig, WH, Pabst, MJ, Jacoby, WB. Glutathione S-transferase. The first enzymic step in mercapturic acid formation. J Biol Chem 1974; 249: 7140–7147.
13. Beutler, E, Blume, KG, Kaplan, JC, Lohr, GV, Ramod, B, Valentine, WN. International Committee for Standardization in Haematology-recommended methods for red cell enzyme analysis. Br J Haematol 1997; 35: 331–340.
14. Aebi, H. Catalase in vitro. Methods Enzymol 1984; 105: 121–126.
15. Yoshida, K, Hirokawa, J, Tagami, S, Kawakami, Y, Urata, Y, Kondo, T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995; 38: 201–210.
16. Anderson, RA, Roussel, AM, Zouari Mahjoub, S, Matheau, JM, Kerkeni, A. Potential antioxidant effects of zinc and chromium supplementation in people with type II dibetes mellitus. J Am CollNutr 2001; 20(3): 212–218.
17. Thornalley, PJ, McLellan, AC, Lo, TW, Benn, J, Sonksen, PH. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci 1996; 91: 575–582.
18. Ciuchi, E, Odetti, P, Prando, R. Relationship between glutathione and sorbitol concentrations in erythrocytes from diabetic patients. Metabolism 1996; 45(5): 611–613.
19. Matsubara, LS, Ferreira, AL, Tornero, MT, Machado, PE, Influence of diabetes mellitus on the glutathione redox system of human red blood cells. Braz. J. Med. Biol Res 1992; 25: 331–335.
20. Straface, E, Rivabene, R, Masella, R, Santulli, M, Paganelli, R, Malorni, W. Structural changes of the erythrcyte as a marker of non-insulin dependent diabetes: protective effect of N-acetylcysteine. Biochem Biophys Res Commun 2002; 290(5): 1393–1398.
21. Borenshtein, D, Ofri, R, Werman, M, Stark, A, Tritschler, HJ, Moeller, W, Madar, Z. Cataract development in diabetic sand rats treated with α-lipoic acid and its γ-linolenic acid conjugate. Diab Metab Res Rev 2001; 17: 44–50.
22. Maritim, AC, Sanders, RA, Watkins, JB. Diabetes, oxidative stres, and antioxidants: A review. J Biochem Mol Toxicol 2003; 17(1): 24–38.
23. Mekinova, D, Chorvatova, V, Volkovova, K, Staruchova, M, Grancicova, E, Klvanova, J, Ondreicka, R. Effectc of intake of exogenous vitamins, C, E and β-carotene on the antioxidative status in kidneys of rats with streptozoticin-induced diabetes. Nahrung 1995; 39: 257–261.
24. Kesavulu, MM, Rao, BK, Giri, R, Vijaya, J, Subramanyam, G, Apparao, C. Lipid peroxidation and antioxidant anzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001; 53: 33–39.
25. Matkovics, B, Kotorman, M, Varga, IS, Hai, DQ, Salgo, L, Novak, Z. Proantioxidant and rhéologie studies in the blood of Type 2 diabetic patients. Acta Physiol Hung 1997; 85 (2): 107–112.
26. Rema, M, Mohan, V, Bhaskar, A, Shanmuga-Sundaram, KR. Does oxidant stress play a role in diabetic retinopathy? Ind J Opthalmo. 1995; 43: 17–21.
27. Kedziora-Kornatowska, KZ, Luciak, M, Blaszczyk, J, Pawlak, W. Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non insulin dependent diabetes with or without diabetic nepropathy. Nephrol Dial Transplant 1998; 13: 2829–2832.
28. Peuchant, E, Christine Delmas-Beauvieux, M, Couchouron, A, Dubourg, L, Jose-Thomas, M, Perromat, A, Clerc, M, Gin, H. Short-term insulin therapy and normoglycaemia, effects on erythrocyte lipid peroxidation in (NIDDM) patients. Diabetes Care 1997; 20: 202–207.
29. Poonam, Y, Sarkar, S, Bhatnagar, D. Lipid peroxidation and antioxidant enzymes in erythrocytes and tissues in aged diabetic rats. Ind J Exp Biol 1997; 35: 389–392.
30. Matkovics, B, Varga, L, Szabo, L, Witas, H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 1982; 14: 77–79.
31. Palandüz, S, Ademoğlu, E, Gokkusu, C, Tamer, S. Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol 2001; 109(5-6): 309–318.
32. Uzel, N, Sivas, A, Uysal, M, Oz, H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res 1987; 19: 89–90.
33. Kaji, H, Jurasaki, M, Ito, K. Increased lipid peroxide value and glutathione peroxidase activity in blood plasma of Type 2 (non-insulin-dependent) diabetic woman. Klin Wochenschr 1985; 63: 765–768.
34. Wiklund, O, Fager, G, Andersson, A, Lundstam, U, Masson, P, Hultberg, B. N-acetylcysteine treatment lowers plasma homocysteine but not serum lypoprotein(a) levels. Atherosclerosis 1996; 119(1): 99–106.
35. Pieper, GM, Siebeneich, W. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 1998; 32(1): 101–105.
36. Kaneto, H, Kajimoto, Y, Miyagawa, J, Matsuoka, T, Fujitani, Y, Umayehara, Y, Hanafusa, T, Matsuzawa, Y, Yamasaki, Y, Hori, M. Benefical effects of antioxidants in diabetes. Diabetes 1999; 48: 2398–2406.
37. De Mattia, G, Bravi, MC, Laurenti, O, Cassone-Faldetts, M, Proietti, A., De Luca, O, Armiento, A, Ferri, C. Reduction of oxidative stress by oral N acetylcysteine treatment diseases plasma solubl vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive patients with non-insulin dependent diabetes. Diabetologia 1998; 41(11): 1392–1396.